You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 4,988,827


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,988,827
Title: Ether isonitriles and radiolabeled complexes thereof
Abstract:Ether-substituted isonitriles, Tc99m complexes thereof, and processes for myocardial tissue radioimaging using the Tc99m complexes.
Inventor(s): Bergstein; Paul L. (Norwood, MA), Subramanyam; Vinayakam (Wilmington, DE)
Assignee: E. I. Du Pont de Nemours and Company (Wilmington, DE)
Application Number:07/056,003
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a Patent: A Detailed Analysis of United States Patent 4,988,827

Introduction

When analyzing a patent, it is crucial to understand its scope, claims, and the broader patent landscape. This article will delve into the specifics of United States Patent 4,988,827, although the patent itself is not provided in the sources, we will use general principles and examples to illustrate the key points.

What is a Patent?

A patent is a form of intellectual property that grants the owner exclusive rights to an invention for a specified period, typically 20 years from the filing date of the patent application[2].

Patent Scope and Claims

The scope of a patent is defined by its claims, which are the legal descriptions of the invention. Here are some key aspects to consider:

Independent and Dependent Claims

Patent claims can be either independent or dependent. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, however, refer back to and further limit an independent claim[3].

Claim Language and Length

The language and length of claims can significantly impact the patent's scope. Independent claim length and count are simple yet effective metrics for measuring patent scope. Broader claims tend to be longer and more complex, while narrower claims are typically shorter and more specific[3].

Analyzing the Claims of a Patent

To analyze the claims of a patent like U.S. Patent 4,988,827, you would need to:

Identify Independent Claims

Look for the independent claims, which are usually the broadest claims in the patent. These claims define the core of the invention.

Examine Dependent Claims

Dependent claims further limit the independent claims and can add specific details or variations of the invention.

Understand Claim Limitations

Each claim has limitations that define what is covered by the patent. These limitations can include specific features, processes, or materials.

Patent Landscape and Prior Art

The patent landscape includes all existing patents and published patent applications that are relevant to the invention. Here’s how to navigate this landscape:

Conduct a Preliminary Search

Use tools like the USPTO's Patent Public Search or international databases such as the European Patent Office's esp@cenet to find existing patents and published applications related to your invention[4].

Global Dossier and Common Citation Document

Utilize the Global Dossier and Common Citation Document (CCD) to see the file histories of related applications and consolidated citation data from multiple patent offices[4].

Obviousness-Type Double Patenting (ODP)

ODP is a critical concept in patent law that prevents an inventor from securing a second, later-expiring patent for an invention covered by a prior patent. This is particularly relevant when dealing with continuation-in-part patents or patents with different patent terms due to Patent Term Adjustments (PTA)[1].

Patent Term Adjustments and Terminal Disclaimers

Patent Term Adjustments (PTA) can extend the term of a patent due to delays in the prosecution process. However, terminal disclaimers, often used to overcome ODP rejections, can limit the term of a patent to prevent extending it past the expiration date of a prior patent[1].

Example from In re Cellect

In the case of In re Cellect, the Federal Circuit dealt with a complex family of patents where ODP analysis was crucial. The court determined that the invalidation of claims under ODP could be traced back to a single family member patent that did not receive a PTA, highlighting the importance of considering the expiration dates and PTA in ODP analyses[1].

Key Takeaways

  • Claims Define Scope: The claims of a patent are the legal boundaries of the invention.
  • Independent and Dependent Claims: Independent claims are broad, while dependent claims are more specific.
  • Patent Landscape: Understanding prior art and related patents is essential for determining the novelty and non-obviousness of an invention.
  • ODP and PTA: Obviousness-Type Double Patenting and Patent Term Adjustments are critical in ensuring that patents do not extend beyond their rightful term.
  • Global Search Tools: Utilize global search tools and databases to ensure comprehensive prior art searches.

FAQs

Q: What is the purpose of independent claims in a patent? A: Independent claims define the broadest scope of the invention and stand alone without reference to other claims.

Q: How do you conduct a preliminary patent search? A: Use tools like the USPTO's Patent Public Search, Global Dossier, and international databases to find relevant existing patents and published applications.

Q: What is Obviousness-Type Double Patenting (ODP)? A: ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a prior patent.

Q: What is the difference between Patent Term Adjustments (PTA) and Patent Term Extensions (PTE)? A: PTA extends the term of a patent due to prosecution delays, while PTE extends the term for certain regulatory delays, such as FDA approval.

Q: Why is it important to analyze the patent landscape? A: Analyzing the patent landscape helps in determining the novelty and non-obviousness of an invention and avoids potential infringement issues.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent and Trademark Office (USPTO) - USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,988,827

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.